Incannex Healthcare (IXHL) Liabilities and Shareholders Equity (2020 - 2026)

Incannex Healthcare (IXHL) posted quarterly Liabilities and Shareholders Equity of $80.3 million for Q1 2026, up 395.67% year-on-year from $16.2 million in Q1 2025, and up 7.04% on a QoQ basis from $75.0 million in Q4 2025.

Incannex Healthcare (IXHL) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $80.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 395.67% year-over-year to $80.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $254.5 million (up 321.3% YoY) and the FY2025 annual result came in at $20.4 million, up 19.94% from the prior year.
  • Liabilities and Shareholders Equity rose to $80.3 million in Q1 2026 per IXHL's latest filing, from $75.0 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for IXHL reached as high as $95.2 million in Q4 2022 and fell as low as $11.1 million in Q4 2024.
  • A 5-year average of $39.3 million and a median of $22.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity sank 76.52% — and 2025, when it surged 575.36%.
  • Year by year, Liabilities and Shareholders Equity stood at $95.2 million in 2022, then plunged by 76.52% to $22.4 million in 2023, then sank by 50.33% to $11.1 million in 2024, then jumped by 575.36% to $75.0 million in 2025, then climbed by 7.04% to $80.3 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $80.3 million, $75.0 million, and $78.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 80.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.28 Mn
Dec 31, 2025 75.01 Mn
Sep 30, 2025 78.72 Mn
Jun 30, 2025 20.45 Mn
Mar 31, 2025 16.20 Mn
Dec 31, 2024 11.11 Mn
Sep 30, 2024 16.05 Mn
Jun 30, 2024 17.05 Mn
Mar 31, 2024 17.25 Mn
Dec 31, 2023 22.36 Mn
Jun 30, 2023 23.78 Mn
Dec 31, 2022 95.22 Mn
Jun 30, 2022 37.88 Mn
Jun 30, 2021 9.33 Mn
Jun 30, 2020 4.24 Mn